Stocktoria
Inogen Inc INGN
Nasdaq · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2014-02-14 · LEI
Inogen Inc financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $348.7M | $335.7M | $315.7M | $377.2M | $358.0M | $308.5M | $361.9M | $358.1M | $249.4M | $202.8M |
| Gross profit | $154.3M | $154.7M | $126.7M | $153.5M | $176.5M | $138.2M | $171.9M | $178.6M | $121.2M | $97.3M |
| R&D expense | $19.4M | $21.6M | $20.8M | $21.9M | $16.6M | $14.1M | $9.4M | $7.0M | $5.3M | $5.1M |
| Operating income | -$30.2M | -$42.5M | -$109.4M | -$85.2M | $9.2M | -$12.0M | $19.8M | $37.9M | $27.6M | $22.9M |
| Interest expense | — | — | — | — | — | — | — | — | — | $6,000 |
| Income tax | -$632,000 | -$588,000 | $105,000 | $504,000 | $15.0M | $549,000 | $3.3M | -$11.4M | $8.7M | $2.2M |
| Net income | -$22.7M | -$35.9M | -$102.4M | -$83.8M | -$6.3M | -$5.8M | $20.9M | $51.8M | $21.0M | $20.5M |
| EPS (diluted) | $-0.86 | $-1.52 | $-4.42 | $-3.67 | $-0.28 | $-0.27 | $0.94 | $2.30 | $0.96 | $0.97 |
| Operating cash flow | -$11.2M | $5.9M | -$3.2M | -$37.5M | $23.6M | $37.0M | $40.6M | $60.0M | $60.5M | $31.0M |
| Free cash flow | -$13.7M | $2.6M | -$8.5M | -$40.9M | $18.2M | $32.6M | $37.5M | $51.9M | $57.6M | $29.3M |
| Cash & equivalents | $103.7M | $113.8M | $125.5M | $187.0M | $235.5M | $212.0M | $198.0M | $196.6M | $143.0M | $92.9M |
| Inventory | $26.0M | $24.8M | $21.8M | $34.1M | $31.9M | $24.8M | $35.7M | $27.1M | $18.8M | $14.3M |
| Total assets | $298.6M | $296.2M | $326.2M | $405.0M | $489.5M | $461.9M | $447.3M | $375.9M | $275.1M | $214.0M |
| Total liabilities | $106.4M | $122.3M | $121.4M | $107.6M | $119.3M | $112.2M | $102.7M | $65.5M | $48.0M | $32.0M |
| Shareholders' equity | $192.2M | $173.9M | $204.8M | $297.4M | $370.2M | $349.6M | $344.6M | $310.4M | $227.0M | $182.1M |
Growth · year-over-year · Revenue CAGR 6.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +3.9% | +6.4% | -16.3% | +5.4% | +16.1% | -14.8% | +1.1% | +43.6% | +23.0% | +27.6% |
| Net income growth | — | — | — | — | — | -127.8% | -59.6% | +146.9% | +2.4% | +77.1% |
| EPS growth | — | — | — | — | — | -128.7% | -59.1% | +139.6% | -1.0% | +73.2% |
| Free cash flow growth | -637.9% | — | — | -325.2% | -44.4% | -12.9% | -27.9% | -9.8% | +96.4% | -18.5% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.